SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-000645
Filing Date
2013-02-11
Accepted
2013-02-11 08:30:39
Documents
22
Period of Report
2013-02-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50559650.htm 8-K 28972
2 EXHIBIT 99.1 a50559650_ex99-1.htm EX-99.1 38722
3 GRAPHIC slide1.jpg GRAPHIC 51816
4 GRAPHIC slide2.jpg GRAPHIC 200682
5 GRAPHIC slide3.jpg GRAPHIC 96397
6 GRAPHIC slide4.jpg GRAPHIC 59615
7 GRAPHIC slide5.jpg GRAPHIC 70557
8 GRAPHIC slide6.jpg GRAPHIC 114864
9 GRAPHIC slide7.jpg GRAPHIC 65730
10 GRAPHIC slide8.jpg GRAPHIC 73464
11 GRAPHIC slide9.jpg GRAPHIC 92217
12 GRAPHIC slide10.jpg GRAPHIC 95661
13 GRAPHIC slide11.jpg GRAPHIC 72341
14 GRAPHIC slide12.jpg GRAPHIC 75886
15 GRAPHIC slide13.jpg GRAPHIC 102112
16 GRAPHIC slide14.jpg GRAPHIC 96310
17 GRAPHIC slide15.jpg GRAPHIC 97113
18 GRAPHIC slide16.jpg GRAPHIC 76103
19 GRAPHIC slide17.jpg GRAPHIC 74703
20 GRAPHIC slide18.jpg GRAPHIC 56944
21 GRAPHIC slide19.jpg GRAPHIC 86043
22 GRAPHIC slide20.jpg GRAPHIC 48327
  Complete submission text file 0001157523-13-000645.txt   2423537
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 13588933
SIC: 2834 Pharmaceutical Preparations